Coronaviruses hijack the cell’s trash disposal system to spread through the body
With Covid-19 cases increasing across the world, researchers are working to better understand how the virus that causes the disease infects cells and spreads...
Brain implants connected to robotic brace to help mobility after stroke?
Brain is still a mystery to even researchers. The latest is: A single patient at Thomas Jefferson University will help researchers learn if brain...
Adolescents’ sleep loss linked to neighbourhood conditions
Adolescents' loss of sleep is linked to conditions in the neighbourhood, according to the findings of a new study.
The study which has been published...
New inflammatory disease found by researchers
Researchers from National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Human Genome Research Institute (NHGRI), and National...
Is immediate immunity against COVID-19 possible? Grifols starts clinical trial of new treatment
Grifols has announced it will begin a clinical trial in Spain to evaluate the safety and efficacy of a new COVID-19 immunity drug based...
Lilly’s donanemab reduces Alzheimer’s disease progression in Phase 2 trial
ALZ results revealed by Eli Lilly and Company at the recent 15th International Conference on Alzheimer's & Parkinson Diseases 2021 (AD/PD 2021) expand on...
Management of long-term effects of Covid-19 ; revelations of NICE & medial bodies
NICE, SIGN and RCGP have set out more details about the United Kingdom guideline on management of the long-term effects of Covid-19 pandemic.
The guideline...
ResMed announces expansion of AirView remote monitoring for ventilation in India
ResMed has announced expansion of AirView for Ventilation, its cloud-based remote monitoring and management platform for respiratory care patients, in India.
According to the leading...
Ampio says its study on Covid-19 patients proceeding to full open enrollment
Ampio Pharmaceuticals Inc has announced that its AP-014 Phase I inhaled Ampion clinical study in Covid-19 patients is proceeding to full open enrollment after...
NeuroRx starts Phase 2/3 study of inhaled ZYESAMI
NeuroRx, Inc. has announced initiation of a Phase 2/3 clinical trial investigating the role of inhaled ZYESAMI (aviptadil).
The trial is being done for the...
